Skip to main content
. 2020 Dec 22;10(1):2. doi: 10.3390/jcm10010002

Figure 1.

Figure 1

Comparison of variables in current cohort and bezlotoxumab-treated patients in MODIFY trial. Numbers show the percentage of patients.